In 2024, Livzon Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Livzon Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 194,440.58a | 155,807.28a | 196,398.1a | |
Total Scope 2 | ||||
Unspecified Calculation Method | 326,718.79a | 358,525.65a | 369,261.9a | |
Total Scope 3 | 1,709,496.18a | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 120.1326a | 89.0844a | 108.2807a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Livzon Pharmaceutical Group amounted to 521,159.37 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Livzon Pharmaceutical Group increased by 1.33%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2024, the total Scope 1 emissions of Livzon Pharmaceutical Group were 194,440.58 metric tons of CO₂ equivalent (tCO₂e).a
Since 2020, Livzon Pharmaceutical Group's Scope 1 emissions have increased by 539.02%, reflecting a rising long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2023), Livzon Pharmaceutical Group's Scope 1 emissions increased by 24.8%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2024, Livzon Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 326,718.79 tCO₂e without specifying the calculation method.a
Since 2020, Livzon Pharmaceutical Group's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 39.94%, reflecting a declining long-term trend in Scope 2 emissions over time.ab
Compared to the previous year (2023), Livzon Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Livzon Pharmaceutical Group's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, Livzon Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology.a
In 2024, Livzon Pharmaceutical Group reported 1,709,496.18 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Livzon Pharmaceutical Group includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Livzon Pharmaceutical Group reported total Scope 3 emissions of 1,709,496.18 metric tons of CO₂ equivalent (tCO₂e).a
In 2024, Livzon Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 194,440.58 tCO₂e and total revenues of USD 1,619 millions. This translates into an emissions intensity of 120.13 tCO₂e per millions USD.a
In 2024, Livzon Pharmaceutical Group reported a Scope 1 emissions intensity of 120.13 tCO₂e per millions USD. Compared to the peer group median of 23.6, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Livzon Pharmaceutical Group ranked 23 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Livzon Pharmaceutical Group among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2024, Livzon Pharmaceutical Group reported a total carbon footprint of 2,230,655.55 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 333.7% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Livzon Pharmaceutical Group's total carbon footprint was Scope 3 emissions, accounting for 76.64% of the company's total carbon footprint, followed by Scope 2 emissions at 14.65%.a